One gene deletion tears off colon cancer's invisibility cloak, boosting immunotherapy

Article excerpt

A study from the University of Calgary shows that removing a single gene makes colon cancer cells a target for immunotherapy, a fundamental breakthrough. The research, published in Cell Reports Medicine, was led by Dr. Arshad Ayyaz, Ph.D., an assistant professor in the Department of Biological Sciences and a member of the Arnie Charbonneau Cancer Institute.